Life Science Financing Term Sheet Review- October 17, 2017
Webinar- Life Science Financing Term Sheet Webinar- Life Science Financing Term Sheet The webinar will be a comprehensive overview of […]
Locust Walk Webinar
2024
Locust Walk Webinar
BioPharma Sell-Side Deal Process Keys to Success – May 3, 2017
Webinar-BioPharma Sell-Side Deal Process Keys to Success Webinar-BioPharma Sell-Side Deal Process Keys to Success This one-hour, interactive webinar will provide
Locust Walk Webinar
BioPharma Buy-Side Deal Process Keys to Success- June 13, 2017
BioPharma Buy-Side Deal Process Keys to Success BioPharma Buy-Side Deal Process Keys to Success The webinar will cover key issues
Locust Walk Webinar
Fundamentals and Key Trends in Life Sciences Private Financing- July 26, 2017
Fundamentals And Recent Trends in Life Sciences Private Financing Fundamentals And Recent Trends in Life Sciences Private Financing This one-hour,
Locust Walk Webinar
Biopharma Valuation Analysis
Webinar- Biopharma Valuation Analysis Biopharma Valuation Analysis The webinar will cover key issues surrounding how to best value a biopharma
News
Garuda Therapeutics Launches with $72 Million Series A Financing
LOCUST WALK NEWS Garuda Therapeutics Launches with $72 Million Series A Financing CAMBRIDGE, Mass.–(BUSINESS WIRE)–Garuda Therapeutics, a company creating off-the-shelf,
News
Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing New Class of Cancer Therapies
LOCUST WALK NEWS Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing
News
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
LOCUST WALK NEWS eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company
News
Locust Walk Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on March 1, 2021
LOCUST WALK NEWS Locust Walk Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on March 1,
News
Locust Walk Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option
LOCUST WALK NEWS Locust Walk Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option PHILADELPHIA